University of Pavia

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: Private

Established: 1361-01-01

Employees: 1K

Market Cap: -

Website: http://www.unipv.it

Clinical Trials

Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension

Phase 3

Conditions: Essential Hypertension

Interventions: Drug: Imidapril
Drug: Candesartan

First Posted Date: 2008-03-26

Last Posted Date: 2008-03-26

Lead Sponsor: University of Pavia

Target Recruit Count: 60

Registration Number: NCT00644475

Locations: 🇮🇹
University of Pavia, Pavia, Italy

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy